Tecentriq 1,200 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FNMWD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,006
Award facts
- Contract value 100% obligated
- $13,005.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $13,005.98 by the Defense Logistics Agency on August 26, 2025. The contract calls for the delivery of Tecentriq (1,200 mg/20 mL vial, 20 mL) and is scheduled for completion by September 17, 2025. This delivery order was issued without a set-aside designation and represents a single line item under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valued through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military healthcare facilities.
Tecentriq, an oncology treatment used in cancer care, will be distributed to support the Department of Defense's medical supply needs. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables. The company's consistent success in securing DLA contracts demonstrates its capability to deliver specialized pharmaceutical products efficiently to military health facilities nationwide, leveraging its woman-owned small business status to compete effectively in federal procurement markets.
Quick answers
Who was awarded contract SPE2DB25FNMWD?
SPE2DB25FNMWD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FNMWD worth?
The government has obligated $13,006 on SPE2DB25FNMWD.
Is contract SPE2DB25FNMWD an order under another contract?
Yes. SPE2DB25FNMWD is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB25FNMWD competed?
The extent of competition for SPE2DB25FNMWD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award